# Insulin Resistance in Non-alcoholic Fatty Liver Disease

> **NCT01289639** · NA · TERMINATED · sponsor: **VA Office of Research and Development** · enrollment: 11 (actual)

## Conditions studied

- Fatty Liver

## Interventions

- **DRUG:** fenofibrate
- **DRUG:** pioglitazone
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01289639
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-10
- **Primary completion:** 2013-08
- **Final completion:** 2014-08
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Low recruitment in intervention study. Baseline data published.
- **Last updated:** 2017-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01289639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01289639, "Insulin Resistance in Non-alcoholic Fatty Liver Disease". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT01289639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*